Détails Publication
Current Status of Prostate Biopsy in Africa: Are We Ready for a Targeted Biopsy?,
Discipline: Médecine clinique
Auteur(s): Ziba Ouima Justin Dieudonne1,2 | Kaleab Habtemichae Gebreselassie1,3 | Taofiq Olayinka Mohammed1,4 | Abdullahi Khalid1,5 | Saleh Abdelkerim Nedjim1,6,7 | Anteneh Tadesse Kifle1,8 | Marcella D. C. Biyouma1,9 | Hassan Dogo1,10 | Christian Agbo1,11 | Muhawenimana Emmanuel1,12 | Mahamat Ali Mahamat1,13 | Ndoye Alain Khassim1,14 | Lazarus John15 | Yameogo Clotaire Alexis Marie Kiemdiba Donega2 | Mohamed Lezrek1,16 | Kirakoya Brahima2 | Ouattara Adama17 | Kabore Fasnewende Aristide
Renseignée par : KIRAKOYA Brahima
Résumé

Background: Prostate cancer remains a significant public health issue globally, with considerable disparities in diagnostic and
management practices, especially in Africa. Traditional diagnostic methods such as transrectal ultrasound‐guided biopsies have
limitations in accuracy and are associated with potential complications. Emerging targeted biopsy techniques promise improved
cancer detection rates and reduced morbidity but face adoption challenges across the African continent due to variable access to
advanced imaging technologies and professional expertise.
Objective: This study aims to evaluate the current practices of prostate biopsy techniques in Africa, focusing particularly on the
readiness for and integration of targeted biopsy methods. It assesses the accessibility, quality, volume of procedures, and
availability of advanced diagnostic tools across different regions.
Results: The survey included 58 centers across five African regions, representing a 70% response rate from an initial 83
invitations sent. Finger‐guided biopsy was the most common method, used by 41 centers, while only one center reported using
MRI fusion biopsy. Thirty‐five centers routinely administered a rectal enema, and nearly all (n = 50) centers employed antibiotic
prophylaxis, predominantly fluoroquinolones. For anesthesia, 12 centers used injectable lidocaine, and 38 centers used intrarectal
lidocaine gel. The number of biopsy cores taken varied, with most centers taking 12, while others used fewer.
Conclusion: The findings indicate a critical need for concerted efforts to bridge the gap in prostate cancer diagnostics and
treatment in Africa. Enhancing the quality of prostate cancer care on the continent requires investments in training, infrastructure,
and standardization of practices. Collaborative efforts towards adopting advanced diagnostic tools and methods are
essential for aligning African practices with global standards, ultimately improving outcomes for prostate cancer patients.

Mots-clés

antibiotic prophylaxis | biopsy anesthesia | MRI fusion | prostate biopsy | prostate cancer | urology practices

936
Enseignants
7719
Publications
49
Laboratoires
101
Projets